Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

cipher pharmaceuticals inc.

POPULAR ARTICLES

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award

Cipher Pharmaceuticals Reports Second Quarter 2026 Results

Cipher Pharmaceuticals Reports Second Quarter 2026 Results

Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call

LATEST ARTICLES

Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of Epuris®

Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of Epuris®

Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders

Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders

Cipher Pharmaceuticals Reports First Quarter Results

Cipher Pharmaceuticals Reports First Quarter Results

Cipher Pharmaceuticals Announces Normal Course Issuer Bid

Cipher Pharmaceuticals Announces Normal Course Issuer Bid

Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call

Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba

Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba

Cipher Pharmaceuticals Reports Third Quarter 2025 Results

Cipher Pharmaceuticals Reports Third Quarter 2025 Results

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Receives Successful Arbitration Award

Cipher Pharmaceuticals Receives Successful Arbitration Award

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

Latest News

Edgewater Wireless Closes Private Placement with Strategic Investment from Silicon Catalyst Angels

Alvopetro Expands Its Western Canadian Growth Platform with Mannville Heavy Oil Farm-In

Ni-Co Energy Launches Approximately 7,500-Metre Drill Program at the Kremer Project; First Hole Targets Kremer-2

Sirios Strengthens its Team with the Appointment of a Vice President, Projects

Lahontan Strengthens Technical, Engineering, and Business Development Team

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Horizon Gold

Horizon Gold (HRN:AU)

HRN:AU

CoTec Holdings

CoTec Holdings (CTH:CC)

CTH:CC

Saga Metals

Saga Metals (SAGA:CC)

SAGA:CC

Mayfair Gold Corp.

Mayfair Gold Corp. (MFG:CC)

MFG:CC

EraNova Metals

EraNova Metals (NOVA:CC)

NOVA:CC

Copper Intelligence

Copper Intelligence (CUAI)

CUAI

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES